Indication

Immunoglobulin A nephropathy

Immunoglobulin A nephropathy is a chronic autoimmune renal disease and the most common primary glomerulonephritis worldwide. Read more about Immunoglobulin A nephropathy

9 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Immunoglobulin A nephropathy therapies.

Showing 1–9 of 9 drugs

FILSPARI (sparsentan)

ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS)·IMMUNOGLOBULIN A NEPHROPATHY·+1
RETROPHIN, INC.

TRUTAKNA (atacicept-vymj)

IMMUNOMODULATOR, B-LYMPHOCYTE STIMULATOR (BLYS)-SPEC INHIB·IMMUNOGLOBULIN A NEPHROPATHY
VERA THERAPEUTI
Filter & compare in the drug finder →Opens the drug finder with Immunoglobulin A nephropathy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Immunoglobulin A nephropathy.

Immunoglobulin A nephropathy is a chronic autoimmune renal disease and the most common primary glomerulonephritis worldwide.

It is pathologically characterized by the deposition of galactose-deficient immunoglobulin A1–containing immune complexes in the glomerular mesangium, triggering mesangial proliferation, local inflammation, and progressive glomerular injury.

Clinically, affected individuals typically present with microscopic or episodic gross hematuria—often concurrent with upper respiratory tract infections—along with varying degrees of proteinuria and hypertension.

The condition can affect patients of all ages, most frequently young adults, and may insidiously progress over years to chronic kidney disease and end-stage renal disease.

Personalize your experience

Follow Immunoglobulin A nephropathy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it